oblimersen and Hematologic-Diseases

oblimersen has been researched along with Hematologic-Diseases* in 1 studies

Trials

1 trial(s) available for oblimersen and Hematologic-Diseases

Article	Year
A phase I-II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798). Investigational new drugs, 2008, Volume: 26, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Doxorubicin; Female; Hematologic Diseases; Humans; Liver Neoplasms; Male; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Thionucleotides; Treatment Outcome	2008

Article

Year

A phase I-II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798).

Investigational new drugs, 2008, Volume: 26, Issue:2

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Doxorubicin; Female; Hematologic Diseases; Humans; Liver Neoplasms; Male; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Thionucleotides; Treatment Outcome

2008